32 Biosciences to Launch $40 Million Series A at J.P. Morgan to Advance First-in-Class GI Mucosal-Immune Therapeutics
Microbiome-focused company receives $6 million in funding to advance gut health platform technologies.
32 Biosciences Set to Attend the 2026 JPM Healthcare Conference
Microbiome-focused company receives $6 million in funding to advance gut health platform technologies.
32 Biosciences Joins Featured Startups in the Midwest Biotech Startup Showcase
Microbiome-focused company receives $6 million in funding to advance gut health platform technologies.
32 Biosciences Surpasses Financing Target, Accelerates Toward Series A and FDA Milestones
Microbiome-focused company receives $6 million in funding to advance gut health platform technologies.
Microbiota-dependent Early-life Programming of Gastrointestinal Motility
Gastrointestinal microbes modulate peristalsis and stimulate the enteric nervous system (ENS), whose development, as in the central nervous system (CNS), continues into the murine postweaning period.Given that adult CNS function depends on stimuli received during critical periods of postnatal development, we hypothesized that adult ENS function, namely motility, depends on microbial stimuli during similar critical […]
UChicago Microbiome Startups Come Together Under New Company to Amplify Results
Two University of Chicago startups are now operating under a parent company, 32 Biosciences – with a shared goal to revolutionize health care through advances in microbiome science. The name is pronounced “three squared biosciences” in homage to its three scientific founders and microbiome medicine experts: University of Chicago professors John Alverdy and Eugene Chang, and assistant professor […]
32 Biosciences Emerges from Stealth Mode with New Approach to Gut Microbiome Medicine
32 Biosciences, pronounced “Three Squared Biosciences,” proudly announces its emergence from stealth mode, with new microbiome diagnostic management tools and microbiome-based interventions. The company intends to revolutionize healthcare with its novel approach to gut microbiome medicine. 32 Biosciences Emerges from Stealth Mode with New Approach to Gut Microbiome Medicine,” published on PR Newswire on January […]